These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 32280305)

  • 21. Immunotherapy: Newer Therapeutic Armamentarium against Cancer Stem Cells.
    Singh SP; Singh R; Gupta OP; Gupta S; Brahma Bhatt ML
    J Oncol; 2020; 2020():3963561. PubMed ID: 32211043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
    Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
    Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural Compounds Targeting Cancer Stem Cells: A Promising Resource for Chemotherapy.
    Das PK; Zahan T; Abdur Rakib M; Khanam JA; Pillai S; Islam F
    Anticancer Agents Med Chem; 2019; 19(15):1796-1808. PubMed ID: 31272363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.
    Kumar D; Gorain M; Kundu G; Kundu GC
    Mol Cancer; 2017 Jan; 16(1):7. PubMed ID: 28137308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer stem cells as a potential therapeutic target in breast cancer.
    Zhang M; Li Z; Zhang X; Chang Y
    Stem Cell Investig; 2014; 1():14. PubMed ID: 27358860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach.
    Malhi S; Gu X
    Expert Opin Drug Deliv; 2015 Jul; 12(7):1177-201. PubMed ID: 25601619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies.
    Khan AQ; Ahmed EI; Elareer NR; Junejo K; Steinhoff M; Uddin S
    Cells; 2019 Aug; 8(8):. PubMed ID: 31530793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung cancer stem cells: origin, features, maintenance mechanisms and therapeutic targeting.
    Heng WS; Gosens R; Kruyt FAE
    Biochem Pharmacol; 2019 Feb; 160():121-133. PubMed ID: 30557553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular signaling in cancer stem cells of tongue squamous cell carcinoma: Therapeutic implications and challenges.
    Joshi P; Waghmare S
    World J Stem Cells; 2023 May; 15(5):438-452. PubMed ID: 37342225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities.
    De Angelis ML; Francescangeli F; Zeuner A
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31619007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implications of cancer stem cells in developing therapeutic resistance in oral cancer.
    Naik PP; Das DN; Panda PK; Mukhopadhyay S; Sinha N; Praharaj PP; Agarwal R; Bhutia SK
    Oral Oncol; 2016 Nov; 62():122-135. PubMed ID: 27865365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer stem cells: a target for overcoming therapeutic resistance and relapse.
    Zhang S; Yang R; Ouyang Y; Shen Y; Hu L; Xu C
    Cancer Biol Med; 2023 Dec; 20(12):985-1020. PubMed ID: 38164743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular and molecular biology of cancer stem cells in melanoma: Possible therapeutic implications.
    Marzagalli M; Raimondi M; Fontana F; Montagnani Marelli M; Moretti RM; Limonta P
    Semin Cancer Biol; 2019 Dec; 59():221-235. PubMed ID: 31265892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer stem cells and tumorigenesis.
    Zhu P; Fan Z
    Biophys Rep; 2018; 4(4):178-188. PubMed ID: 30310855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNAs as Theranostics Targets in Oral Carcinoma Stem Cells.
    Hsieh PL; Liao YW; Pichler M; Yu CC
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32028645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can lung cancer stem cells be targeted for therapies?
    Wu X; Chen H; Wang X
    Cancer Treat Rev; 2012 Oct; 38(6):580-8. PubMed ID: 22436486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic Targeting of Cancer Stem Cells via Modulation of the Renin-Angiotensin System.
    Roth IM; Wickremesekera AC; Wickremesekera SK; Davis PF; Tan ST
    Front Oncol; 2019; 9():745. PubMed ID: 31440473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.
    Li Y; Jiang F; Liu Q; Shen J; Wang X; Li Z; Zhang J; Lu X
    Toxicol Sci; 2015 Jan; 143(1):156-64. PubMed ID: 25304214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting oral cancer stemness and chemoresistance by isoliquiritigenin-mediated GRP78 regulation.
    Hu FW; Yu CC; Hsieh PL; Liao YW; Lu MY; Chu PM
    Oncotarget; 2017 Nov; 8(55):93912-93923. PubMed ID: 29212198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.